-2.6R
PR Breakout: Radius Health Inc RDUS reported positive phase 3 top-line data for investigational osteoporosis therapy abaloparatide at the ASBMR.
I was trying to buy a pullback to price support/9EMA. I didn't exit soon enough, because I thought it would bounce.
Later I found why none of the biotechs bounced today.
John Welsh @johnwelshtrades 10h10 hours ago
$LLY is bad. Biotech is a short or avoid today. Let's crash these stocks into the democratic debate Tuesday night.
John Welsh @johnwelshtrades 10h10 hours ago
Depending on $LLY halt news today, biotech may get destroyed into Tuesdays Democratic TV event where they hammer drug prices
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2015-10-12 09:59:14 | RDUS | buy | $60.020 | long |
2015-10-12 10:14:12 | RDUS | sell | $58.500 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!